Universitätsklinikum Schleswig-Holstein (UKSH)

Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care (2024) Heinlein L, Maron RC, Hekler A, Haggenmüller S, Wies C, Utikal JS, Meier F, et al. Journal article Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals (2024) Liwinski T, Auer MK, Schröder J, Pieknik I, Casar C, Schwinge D, Henze L, et al. Journal article Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors (2024) Kuehn JC, Metzger P, Neidert N, Matysiak U, Gräßel L, Philipp U, Bleul S, et al. Journal article Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients (2024) Hovorkova L, Winkowska L, Skorepova J, Krumbholz M, Benesova A, Polivkova V, Alten J, et al. Journal article Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease (2024) Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching P, et al. Journal article Which Comprehensive Geriatric Assessment (CGA) instruments are currently used in Germany: a survey (2024) Kudelka J, Ollenschläger M, Dodel R, Eskofier B, Hobert MA, Jahn K, Klucken J, et al. Journal article Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device (2024) Kirk C, Küderle A, Micó-Amigo ME, Bonci T, Paraschiv-Ionescu A, Ullrich M, Soltani A, et al. Journal article Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy (2024) Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, Vathiotis I, et al. Journal article Quality of care of oncological patients with home parenteral nutrition (2024) Schneider A, Baur C, Zopf Y, Török HP, Sina C, Prinz C, Mönnich H, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article